Publications by Zora Scientists
2011
|
|
||
| Hoeks J, Mensink M, Hesselink MK, Ekroos K, Schrauwen P. | Long- and Medium-Chain Fatty Acids Induce Insulin Resistance to a Similar Extent in Humans Despite Marked Differences in Muscle Fat Accumulation |
J Clin Endocrinol Metab. 2011 Oct 26. [Epub ahead of print] |
|
|
||
| Jung HR, Sylvänne T, Koistinen KM, Tarasov K, Kauhanen D, Ekroos K. | High throughput quantitative molecular lipidomics | Biochimica et Biophysica Acta (BBA), Article in press, Available online July 2011 |
|
|
||
| Schunkert H. et al. | Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease | Nature Genetics, 2011; 43(4): 333-340. |
|
|
||
| Perman JC. et al. | The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction | J Clin Invest. 2011; 121(7): 2625-2640. |
|
|
||
2010
|
|
||||
| Ekroos K, Jänis M, Tarasov K, Hurme R, Laaksonen R | Lipidomics: A Tool for Studies of Atherosclerosis | Current Atherosclerosis Reports, 2010; 12(4): 273-281 | ||
|
|
||||
| Teslovich, TM et al. | Biological, clinical and population relevance of 95 loci for blood lipids | Nature, 2010; 466(5): 707-713 | ||
|
|
||||
2009
|
|
||||
| Ejsing CS, Sampaio JL, Surendranath V, Duchoslav E, Ekroos K, Klemm RW, Simons K, Shevchenko A. | Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry | Proc Natl Acad Sci USA. 2009 Jan 27. | ||
|
|
||||
| Ståhlman M, Ejsing CS, Tarasov K, Perman J, Borén J, Ekroos K. | High-Throughput Shotgun Lipidomics by Quadrupole Time-of-Flight Mass Spectrometry | Journal of Chromatography B. 2009 | ||
|
|
||||
| Sergent O, Ekroos K, Lefeuvre-Orfila L, Rissel M, Forsberg G-B, Oscarsson J, Andersson TB,Lagadic-Gossmann D. |
Ximelagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes |
Toxicology in Vitro, 2009 Jul 16. | ||
|
|
||||
| Hiukka a. et al. | ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan | Diabetes, 2009; Vol 58, 2018 - 2026 | ||
|
|
||||
2008
| Ekroos, K. | Unraveling glycerophospholipidomes by lipidomics, in “Biomarker methods in drug discovery and development, Methods in pharmacology and toxicology” |
Humana Press, 2008. |
|
|
||
| Tarassov K, Messier V, Landry CR, Radinovic S, Molina MM, Shames I, Malitskaya Y, Vogel J, Bussey H, Michnick SW. | An in Vivo Map of the Yeast Protein Interactome |
Science (2008); 320: 1465-1470. |
|
|
||
| Orešič M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T. et al. | Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes |
JEM (2008) 205, No. 13, 2975-2984. |
|
|
||
| Jänis MT, Laaksonen R, Orešič M. | Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs |
Expert Opin. Drug Metab. Toxicol. (2008) 4(6):665-680. |
2007
| Lelliott CJ, Ljungberg A, Ahnmark A, William-Olsson L, Ekroos K, Elmgren A, Arnerup G, Shoulders CC, Oscarsson J, Lindén D. | Hepatic PGC-1β over-expression induces combined hyperlipidemia and modulates the response to PPARα Activation. |
Arterioscler Thromb Vasc Biol. (2007) 27, 2707-2713. |
|
|
||
| Schick B, Laaksonen R, Frohlich J, Päivä H, Lehtimäki T, Humphries KH, Côté H. | Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin |
Clin Pharmacol Ther (2007);81(5):650-3. |
|
|
||